NIH-funded research R01 grant

Understanding how fentanyl causes sudden death and finding ways to prevent it

Official title: Mechanism and Countermeasure of Fentanyl-Induced Sudden Death

Funded at Lovelace Biomedical Research Institute · NIH-10984969 · Data updated 2026-11-12

This study is looking into how fentanyl can cause breathing problems that might lead to sudden death, and it's aimed at finding ways to help people who might overdose on opioids by understanding the nerves involved in this process.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionLovelace Biomedical Research Institute
NIH-funded
Lab location1 site (Albuquerque, United States)
Project startJanuary 1, 2023
Project endNovember 30, 2026
Funding year2025
Award (this year)$849,782
NIH project number5R01HL163512-03
Project IDNIH-10984969 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults who are at risk of fentanyl overdose, particularly those using illicit fentanyl.

Less likely to help

Patients who do not use opioids or are not at risk of opioid overdose may not benefit from this research.

What this research studies

This research investigates the mechanisms behind fentanyl-induced sudden death, particularly focusing on how fentanyl affects breathing and leads to apnea. The study aims to identify the specific nerve pathways involved and explore potential countermeasures that could prevent fatal outcomes in cases of overdose. By examining the role of bronchopulmonary C-fibers and their interaction with fentanyl, the research seeks to develop effective treatments for individuals who experience life-threatening respiratory depression. This work is crucial for addressing the public health crisis of opioid overdoses.

Why it matters

Potential benefit: If successful, this research could lead to new treatments that prevent sudden death from fentanyl overdoses, potentially saving many lives.

How similar studies have gone: While there have been studies on opioid overdose treatments, the specific mechanisms and countermeasures being investigated in this research are novel and have not been extensively tested.

Where this research is happening

  • Lovelace Biomedical Research Institute
    Albuquerque, United States
    Active

Researchers

  • Principal investigator: Xu, Fadi — Lovelace Biomedical Research Institute
  • Study coordinator: Xu, Fadi

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.